Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Xenoacremonium recifei strain:IHEM 4405

ABSTRACT: Xenoacremonium recifei IHEM 4405 Genome sequencing and assembly

PROVIDER: PRJNA573891 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Trichophyton yaoundei strain:IHEM 4711

Project description:Trichophyton yaoundei IHEM 4711 Genome sequencing and assembly

| PRJNA574011 | ENA

Trichophyton kuryangei strain:IHEM 26527

Project description:Trichophyton kuryangei IHEM 26527 Genome sequencing and assembly

| PRJNA574014 | ENA

Chrysosporium tropicum strain:IHEM 4434

Project description:Chrysosporium tropicum IHEM 4434 Genome sequencing and assembly

| PRJNA656725 | ENA

Aspergillus floridensis strain:IHEM 21069

Project description:Aspergillus floridensis IHEM 21069 Genome sequencing and assembly

| PRJNA574013 | ENA

Trichophyton simii strain:IHEM 4420

Project description:Trichophyton simii IHEM 4420 Genome sequencing and assembly

| PRJNA656715 | ENA

Aspergillus welwitschiae strain:IHEM 2864

Project description:Aspergillus welwitschiae strain:IHEM 2864 Genome sequencing and assembly

| PRJNA573887 | ENA

Scedosporium apiospermum strain:IHEM 14462

Project description:Scedosporium apiospermum strain:IHEM 14462 Genome sequencing and assembly

| PRJNA244532 | ENA

Microsporum audouinii strain:IHEM 2214

Project description:Microsporum audouinii strain:IHEM 2214 Genome sequencing and assembly

| PRJNA730373 | ENA

Scedosporium apiospernum complex

Project description:Scedosporium boydii strain IHEM 23826, Genome sequencing and assembly.

| PRJNA382498 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data